Veea Inc. shares surged 149.34% to close at $5.71 after announcing a proposed business combination with NovaGen Group B.V. and a separate $10 million investment commitment from GeoNova Capital. The transaction would create NovaGen Health Networks, combining Veea’s edge-computing, connectivity, cybersecurity, storage and artificial-intelligence capabilities with NovaGen’s regenerative medicine software, cellular reprogramming science and clinical services. The companies estimate the combined organization’s value at approximately $750 million. An earlier account reported a 172.05% gain to $6.23, creating a discrepancy in the reported move. Initial deployments are planned for NovaGen treatment facilities and affiliated medical centers in the fourth quarter of 2026, while definitive agreements remain pending and Veea plans to continue serving its existing clients and markets.